Front-line XELOXA regimen delays progression of metastatic colorectal cancer Journal Article

  

Author:	Lichtman, S. M.
Article Title:	Front-line XELOXA regimen delays progression of metastatic colorectal cancer
Keywords:	cancer survival; clinical trial; drug tolerability; neutropenia; bevacizumab; fluorouracil; cancer combination chemotherapy; cancer growth; diarrhea; drug dose reduction; note; capecitabine; follow up; colorectal cancer; metastasis; peripheral neuropathy; antineoplastic activity; age; irinotecan; folinic acid; drug response; nausea and vomiting; oxaliplatin; hand foot syndrome
Journal Title:	The Oncology Report
Issue:	Spring
ISSN:	1548-5323
Publisher:	International Medical News Group LLC
Date Published:	2005-03-01
Start Page:	45
End Page:	46
Language:	English
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-16844369211&partnerID=40&md5=849ea41f2f5c92d3402291353b0023bd
Notes:	--- - "Export Date: 24 October 2012" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/35400